Dimensional Fund Advisors LP lessened its holdings in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 8.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,415,376 shares of the technology company's stock after selling 129,685 shares during the quarter. Dimensional Fund Advisors LP owned approximately 5.22% of Plexus worth $181,348,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in the business. Fox Run Management L.L.C. boosted its holdings in shares of Plexus by 7.2% during the first quarter. Fox Run Management L.L.C. now owns 2,017 shares of the technology company's stock worth $258,000 after purchasing an additional 135 shares during the period. Neuberger Berman Group LLC purchased a new stake in Plexus in the 1st quarter worth approximately $261,000. HighTower Advisors LLC boosted its stake in shares of Plexus by 33.3% during the 1st quarter. HighTower Advisors LLC now owns 3,965 shares of the technology company's stock valued at $508,000 after buying an additional 990 shares during the period. Public Sector Pension Investment Board boosted its stake in shares of Plexus by 26.4% during the 1st quarter. Public Sector Pension Investment Board now owns 85,720 shares of the technology company's stock valued at $10,983,000 after buying an additional 17,926 shares during the period. Finally, Nuveen LLC purchased a new position in shares of Plexus during the 1st quarter valued at $22,975,000. Institutional investors and hedge funds own 94.45% of the company's stock.
Plexus Stock Performance
Plexus stock traded down $0.22 during trading hours on Monday, reaching $137.04. 134,156 shares of the company were exchanged, compared to its average volume of 159,419. Plexus Corp. has a 12 month low of $103.43 and a 12 month high of $172.89. The company has a current ratio of 1.58, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The stock has a 50-day moving average of $132.56 and a 200 day moving average of $129.96. The firm has a market cap of $3.70 billion, a price-to-earnings ratio of 23.35 and a beta of 0.80.
Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.19. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same quarter last year, the firm posted $1.45 earnings per share. The company's quarterly revenue was up 6.0% compared to the same quarter last year. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. As a group, research analysts anticipate that Plexus Corp. will post 5.9 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on PLXS shares. Stifel Nicolaus set a $140.00 price objective on Plexus in a report on Thursday, July 24th. Needham & Company LLC dropped their target price on Plexus from $162.00 to $158.00 and set a "buy" rating on the stock in a research report on Thursday, July 24th. Benchmark reaffirmed a "buy" rating and set a $160.00 price target on shares of Plexus in a research note on Wednesday, June 4th. Wall Street Zen cut Plexus from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 16th. Finally, Sidoti upgraded Plexus from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $135.00 to $150.00 in a report on Friday, July 25th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $152.00.
View Our Latest Analysis on Plexus
Insider Transactions at Plexus
In other Plexus news, insider Michael J. Running sold 646 shares of the business's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $130.05, for a total transaction of $84,012.30. Following the completion of the transaction, the insider owned 630 shares of the company's stock, valued at $81,931.50. The trade was a 50.63% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Patrick John Jermain sold 2,178 shares of the firm's stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $130.42, for a total value of $284,054.76. Following the completion of the sale, the chief financial officer directly owned 23,459 shares in the company, valued at approximately $3,059,522.78. This represents a 8.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 12,484 shares of company stock worth $1,626,335. Corporate insiders own 1.76% of the company's stock.
Plexus Profile
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More

Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.